Olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer

Supporting evidence

• Evaluation report

• TA887 committee papers (PDF 470 KB)

  Published:

  10 May 2023

• TA831 appraisal consultation 1 committee papers (PDF 5.78 MB)

  Published:

  10 May 2023

• TA831 appraisal consultation 2 committee papers (PDF 692 KB)

  Published:

  10 May 2023

• TA831 final appraisal determination committee papers (PDF 638 KB)

  Published:

  10 May 2023